- CRS Publications
- News
News
Authors:
Date:
Business Wire: August 15, 2016 – LOUGHBOROUGH, England – Nemaura Pharma has been awarded the prestigious 2016 Frost & Sullivan award for best practices in enabling technology leadership in the transdermal drug delivery industry.
The analysts stated that “Nemaura Pharma’s drug delivery…
Authors:
Date:
Christiana Care Health System: September 12, 2017 – Wilmington, DE, U.S.A. – To accelerate the development of next-generation cancer therapies, the Gene Editing Institute of the Helen F. Graham Cancer Center & Research Institute at Christiana Care Health System has agreed to provide genetically…
Authors:
Date:
PRNewswire: July 17, 2017 – BOSTON, MA, U.S.A. – The Luye Life Sciences Group announced today the opening of its new Boston R&D Center, the second global R&D facility set up in the United States after the one in New Jersey. The Boston R&D Center will collaborate with multiple business…
Authors:
Overview
While some biologics are intended to treat diseases and medical conditions, others are designed to prevent or diagnose diseases. The therapeutic biological products (TBPs) regulated by the Center for Drug Evaluation and Research (CDER) of the U.S. FDA typically refer to the following…
Authors:
My name is Assaf Zinger, and I am a Ph.D. student in Avi Schroeder’s lab at the Technion, Israel. I’d like to share with you the story of the first YICRS conference.
So, like…
Authors:
Overview
While some biologics are intended to treat diseases and medical conditions, others are designed to prevent or diagnose diseases. The therapeutic biological products (TBPs) regulated by the Center for Drug Evaluation and…
